Investing Profile

Jeffrey Tong(90)

VCInvestor
Partner at Third Rock Ventures
thirdrockventures.com/people/...Palo Alto, California
Photo of Jeffrey Tong, Partner at Third Rock Ventures
Your Intro Paths to Jeffrey Tong

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Jeffrey Tong's investing connections

Picture
Picture
Picture

17 Investors

Connected to James Currier (NFX), Aileen Lee (Cowboy Ventures), Gigi Levy-Weiss (NFX), and 14 other investors on Signal.

Networks Jeffrey is a member of
Harvard University Network
402 CONNECTIONS
Harvard University Network
402 CONNECTIONS
McKinsey & Company Network
274 CONNECTIONS
Third Rock Ventures Network
16 CONNECTIONS

Find Jeffrey Tong on

cb
Current Investing Position
Third Rock Ventures Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
16
Current Fund Size
$770M

Jeffrey Tong is on these Sector & Stage Rankings

Jeffrey Tong's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Terremoto Biosciences
Series CApr 2026$110M
Series BNov 2023$180M
Series AMay 2022$75M
$360M
Co-investors: Peter Thompson (OrbiMed), Kevin Koch (OrbiMed), Reid Huber (Third Rock Ventures)
ARTBIO
Series BJul 2025$130M
Series ADec 2023$90M
$250M
Co-investors: Robert Mittendorff (B Capital Group), Alexander Pasteur (F-Prime Capital Partners), Maha Katabi (Sofinnova Investments)
Trace Neuroscience
Series ANov 2024$100M
$100M
Co-investors: Anthony Philippakis (GV (Google Ventures)), David Grayzel (Atlas Venture)
Marea Therapeutics
Series BJun 2024$190M
Series AJun 2024$65M
$260M
Co-investors: Charles Homcy (Third Rock Ventures), Maha Katabi (Sofinnova Investments), Aaron Royston (venBio), Chris Garabedian (Perceptive Advisors)
Asher Bio
Series CApr 2024$55M
Series BSep 2021$110M
Series AMar 2021$55M
$220M
Co-investors: Reid Huber (Third Rock Ventures), Jake Simson (RA Capital), Evan Cheng (Mysten Labs), Alice Zhang
Septerna
Series BJul 2023$150M
Series AJan 2022$100M
$250M
Co-investors: Jeffrey Finer (Third Rock Ventures), Jake Simson (RA Capital), Abe Bassan (Samsara BioCapital), Alan Ezekowitz (Third Rock Ventures)
Ambys Medicines
Series ADec 2021$47M
Series AAug 2018$60M
$110M
Co-investors: Charles Homcy (Third Rock Ventures)
Takko
SeedN/A$4M
$4M

Jeffrey Tong's Experience

Partner Third Rock Ventures2016 - Present
Executive Chairman of the Board CelgenePresent
Executive Chairman of the Board Delinia2016 - 2017
Member of the Board of Directors Nora Therapeutics2010 - 2016
President & CEO Nora Therapeutics2010 - 2015
Vice President, Corporate and Product Development Infinity Pharmaceuticals2001 - 2010
Consultant McKinsey & Company2000 - 2001

Jeffrey Tong's Education

Harvard University AB AM, MMS, PhD
Harvard University AB, AM, MMS, PhD AM, MMS, PhD

Founders who looked at Jeffrey Tong's profile also looked at these Scouts & Angels

Photo of Christopher Priebe, Angel

Photo of Justin Waldron, Angel

Photo of Errol Damelin, Angel

Photo of Brad Holden, Managing Partner